ATE423141T1 - Humaner igm-antikörper, der in hiv-infizierten zellen apoptose induziert, und mittel gegen hiv- infektion - Google Patents

Humaner igm-antikörper, der in hiv-infizierten zellen apoptose induziert, und mittel gegen hiv- infektion

Info

Publication number
ATE423141T1
ATE423141T1 AT03761838T AT03761838T ATE423141T1 AT E423141 T1 ATE423141 T1 AT E423141T1 AT 03761838 T AT03761838 T AT 03761838T AT 03761838 T AT03761838 T AT 03761838T AT E423141 T1 ATE423141 T1 AT E423141T1
Authority
AT
Austria
Prior art keywords
hiv
infected cells
human igm
induces apoptosis
igm antibodies
Prior art date
Application number
AT03761838T
Other languages
English (en)
Inventor
Hidechika Okada
Noriko Okada
Original Assignee
Inst Nagoya Ind Science Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nagoya Ind Science Res filed Critical Inst Nagoya Ind Science Res
Application granted granted Critical
Publication of ATE423141T1 publication Critical patent/ATE423141T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03761838T 2002-07-01 2003-06-30 Humaner igm-antikörper, der in hiv-infizierten zellen apoptose induziert, und mittel gegen hiv- infektion ATE423141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002227953 2002-07-01
JP2003074316 2003-03-18

Publications (1)

Publication Number Publication Date
ATE423141T1 true ATE423141T1 (de) 2009-03-15

Family

ID=30002402

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03761838T ATE423141T1 (de) 2002-07-01 2003-06-30 Humaner igm-antikörper, der in hiv-infizierten zellen apoptose induziert, und mittel gegen hiv- infektion

Country Status (9)

Country Link
US (1) US7595050B2 (de)
EP (1) EP1533320B1 (de)
JP (1) JP4310498B2 (de)
CN (1) CN1665842B (de)
AT (1) ATE423141T1 (de)
AU (1) AU2003244158A1 (de)
CA (1) CA2491859A1 (de)
DE (1) DE60326243D1 (de)
WO (1) WO2004003021A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107847591B (zh) * 2015-04-17 2023-07-28 Igm生物科学股份有限公司 多价人免疫缺陷病毒抗原结合分子及其应用
CN112094352B (zh) * 2020-09-27 2021-03-16 南京妙迪生物科技有限公司 一种抗IgM单克隆抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2067031C (en) 1991-04-26 2003-02-18 Shigekazu Nagata Dna coding for human cell surface antigen
TW505656B (en) 1995-12-18 2002-10-11 Otsuka Pharma Co Ltd Sugar-chain-recognizing antibodies and pharmaceutical composition for HIV infectious diseases
AU2185199A (en) 1998-09-30 2000-04-17 Yoko Aida Apoptosis inducers

Also Published As

Publication number Publication date
EP1533320B1 (de) 2009-02-18
AU2003244158A1 (en) 2004-01-19
WO2004003021A1 (ja) 2004-01-08
CA2491859A1 (en) 2004-01-08
US7595050B2 (en) 2009-09-29
CN1665842B (zh) 2011-09-28
JP4310498B2 (ja) 2009-08-12
JPWO2004003021A1 (ja) 2005-10-27
CN1665842A (zh) 2005-09-07
EP1533320A4 (de) 2006-05-03
DE60326243D1 (de) 2009-04-02
EP1533320A1 (de) 2005-05-25
US20060292160A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
RU2325389C2 (ru) Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью
NO20065227L (no) Menoklonale antistoff mot hepatocytt vekstfaktor
FR19C1028I2 (fr) Anticorps greffes avec cdr humains et fragments de ces anticorps
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
NL300889I2 (nl) Trifluridine in combinatie met tipiracilhydrochloride
ATE388167T1 (de) Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
MXPA04011612A (es) Uso oftalmologico de roflumilasto para el tratamiento de enfermedades del ojo.
ATE200077T1 (de) Substituierte phenylimidazolidine, ihre anwendung als medikamente und die sie enthaltende pharmazeutische präparate
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
EA200701175A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
ITMO20000124A0 (it) Dispositivo medicale preassemblato monouso per la somministrazione a pazienti di almeno due medicamenti in proporzioni prestabilite
ATE226447T1 (de) Anti-fas antikörper gegen rheumatische krankheiten
EA200301187A1 (ru) Применение азитромицина для производства лекарственного средства для лечения неинфекционных воспалительных заболеваний
EE200100366A (et) Antikehade kasutamine vähivastase farmatseutilisekompositsiooni valmistamiseks
EE200300363A (et) N-(püridinüül)-1H-indool-1-amiinühendite kasutamine ravimi valmistamiseks, mis on ette nähtud müeliinikaotusega seotud haiguste ja seisundite ravimiseks
EA200400399A1 (ru) Способы лечения легочных заболеваний
DE60205311D1 (de) Wegwerfwindel offenen Typs
ATE423141T1 (de) Humaner igm-antikörper, der in hiv-infizierten zellen apoptose induziert, und mittel gegen hiv- infektion
CY1111900T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties